826 results on '"Brüggemann, Monika"'
Search Results
2. Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)
3. Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
4. The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category
5. Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
6. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols
7. Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology
8. Structure and content of the EU-IVDR: Current status and implications for pathology
9. Die Verordnung (EU) 2017/746 (IVDR) in der Praxis: Umsetzung von Anhang I in der Pathologie
10. Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
11. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma
12. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
13. First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
14. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
15. Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry
16. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
17. Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group
18. High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
19. Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
20. Struktur und Inhalt der EU-IVDR: Bestandsaufnahme und Implikationen für die Pathologie
21. Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies
22. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL
23. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
24. Molekulare Diversität der akuten lymphoblastischen Leukämie: Innovationen in Diagnostik und Therapie
25. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia
26. Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG): a multicentre, open-label, phase 2 trial
27. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
28. Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
29. An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse
30. Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study.
31. Marker für minimale Resterkrankung: Minimal Residual Disease
32. Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq
33. Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia
34. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
35. Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
36. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study
37. Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1
38. Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing.
39. CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia
40. Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
41. Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia
42. Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia
43. Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
44. P-199 Novel antibodies identified by phage display induce direct myeloma cell death
45. The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
46. P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
47. P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13
48. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
49. Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
50. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.